Iktos

Iktos is a French startup that has developed a truly innovative and disruptive artificial intelligence technology for ligand-based drug design, focusing on MPO (multi-parameter optimization). Iktos's innovative algorithms are based on state-of-the-art deep learning models known as generative models, capable of designing new, druggable, and synthesizable molecules with unprecedented speed and performance under given blueprint constraints.